AGP Executive Report
Last update: 24 minutes agoNew Antibiotic Breakthrough: McMaster researchers report a new antibiotic, manikomycin, that targets a previously unknown bacterial vulnerability and shows early activity against drug-resistant pathogens like Salmonella and E. coli. Cancer Drug Access: Novartis Canada and the pan-Canadian Pharmaceutical Alliance reached a milestone deal for public reimbursement of Scemblix (asciminib) for newly diagnosed Ph+ chronic myeloid leukemia. Pancreatic Cancer Trial Push: Princess Margaret’s Dr. Jennifer Knox says Health Canada hasn’t received a license application yet, but she expects clinical trials for a pill (daraxonrasib) that doubled survival in a Phase 3 study. Public Health Planning: PAHO urges countries to boost measles surveillance and vaccination ahead of mass gatherings like the 2026 FIFA World Cup. Housing & Rights: Canada’s Federal Housing Advocate calls for a renewed National Housing Strategy and Build Canada Homes agency to be grounded in human rights. Whale Relocation Update: Ottawa endorsed moving Marineland’s remaining captive belugas and dolphins to aquariums in the U.S. and Spain, with permits underway.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
